nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—HTR2A—conduct disorder	0.926	1	CbGaD
Epinastine—HTR7—autonomic nervous system—conduct disorder	0.00291	0.421	CbGeAlD
Epinastine—HTR7—Serotonin receptors—HTR2A—conduct disorder	0.00269	0.0472	CbGpPWpGaD
Epinastine—HRH2—Monoamine GPCRs—DRD4—conduct disorder	0.0024	0.042	CbGpPWpGaD
Epinastine—HRH2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00202	0.0353	CbGpPWpGaD
Epinastine—HTR7—Monoamine GPCRs—DRD4—conduct disorder	0.00184	0.0322	CbGpPWpGaD
Epinastine—HTR2A—autonomic nervous system—conduct disorder	0.00182	0.262	CbGeAlD
Epinastine—Mirtazapine—DRD4—conduct disorder	0.0017	0.174	CrCbGaD
Epinastine—HRH2—Monoamine GPCRs—HTR2A—conduct disorder	0.00157	0.0274	CbGpPWpGaD
Epinastine—HTR7—Amine ligand-binding receptors—DRD4—conduct disorder	0.00155	0.0271	CbGpPWpGaD
Epinastine—HRH2—G alpha (s) signalling events—CGA—conduct disorder	0.00149	0.026	CbGpPWpGaD
Epinastine—HRH2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00132	0.023	CbGpPWpGaD
Epinastine—HTR7—Monoamine GPCRs—HTR2A—conduct disorder	0.0012	0.021	CbGpPWpGaD
Epinastine—HTR2A—Monoamine GPCRs—DRD4—conduct disorder	0.00118	0.0206	CbGpPWpGaD
Epinastine—HRH1—Monoamine GPCRs—DRD4—conduct disorder	0.00117	0.0206	CbGpPWpGaD
Epinastine—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.00115	0.0202	CbGpPWpGaD
Epinastine—HTR7—G alpha (s) signalling events—CGA—conduct disorder	0.00114	0.0199	CbGpPWpGaD
Epinastine—ADRA2A—Monoamine GPCRs—DRD4—conduct disorder	0.00107	0.0188	CbGpPWpGaD
Epinastine—Mirtazapine—SLC6A4—conduct disorder	0.00102	0.105	CrCbGaD
Epinastine—HTR7—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00101	0.0177	CbGpPWpGaD
Epinastine—HTR2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.000989	0.0173	CbGpPWpGaD
Epinastine—HRH1—Amine ligand-binding receptors—DRD4—conduct disorder	0.000987	0.0173	CbGpPWpGaD
Epinastine—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.000969	0.017	CbGpPWpGaD
Epinastine—ADRA2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0009	0.0158	CbGpPWpGaD
Epinastine—HTR7—GPCRs, Other—DRD4—conduct disorder	0.000817	0.0143	CbGpPWpGaD
Epinastine—Mirtazapine—HTR2A—conduct disorder	0.000786	0.0804	CrCbGaD
Epinastine—HRH1—Monoamine GPCRs—HTR2A—conduct disorder	0.000766	0.0134	CbGpPWpGaD
Epinastine—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.000752	0.0132	CbGpPWpGaD
Epinastine—Mianserin—SLC6A4—conduct disorder	0.000752	0.0769	CrCbGaD
Epinastine—HRH2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000708	0.0124	CbGpPWpGaD
Epinastine—ADRA2A—Monoamine GPCRs—HTR2A—conduct disorder	0.000699	0.0122	CbGpPWpGaD
Epinastine—Nortriptyline—SLC6A4—conduct disorder	0.000672	0.0687	CrCbGaD
Epinastine—HRH1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000644	0.0113	CbGpPWpGaD
Epinastine—Trimipramine—SLC6A4—conduct disorder	0.000632	0.0647	CrCbGaD
Epinastine—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000632	0.0111	CbGpPWpGaD
Epinastine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000619	0.0108	CbGpPWpGaD
Epinastine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000597	0.0105	CbGpPWpGaD
Epinastine—ADRA2A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000587	0.0103	CbGpPWpGaD
Epinastine—Mianserin—HTR2A—conduct disorder	0.000578	0.0591	CrCbGaD
Epinastine—HRH2—brain—conduct disorder	0.000554	0.08	CbGeAlD
Epinastine—Desipramine—SLC6A4—conduct disorder	0.000553	0.0566	CrCbGaD
Epinastine—HTR7—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000543	0.00951	CbGpPWpGaD
Epinastine—HRH2—GPCR ligand binding—CGA—conduct disorder	0.00054	0.00945	CbGpPWpGaD
Epinastine—HTR7—GPCRs, Other—HTR2A—conduct disorder	0.000533	0.00933	CbGpPWpGaD
Epinastine—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.000523	0.00916	CbGpPWpGaD
Epinastine—Nortriptyline—HTR2A—conduct disorder	0.000516	0.0528	CrCbGaD
Epinastine—Trimipramine—HTR2A—conduct disorder	0.000486	0.0497	CrCbGaD
Epinastine—Imipramine—SLC6A4—conduct disorder	0.000469	0.048	CrCbGaD
Epinastine—Amitriptyline—SLC6A4—conduct disorder	0.000466	0.0477	CrCbGaD
Epinastine—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000463	0.00811	CbGpPWpGaD
Epinastine—HTR7—Circadian rythm related genes—SLC6A4—conduct disorder	0.000461	0.00807	CbGpPWpGaD
Epinastine—HTR7—Circadian rythm related genes—DRD4—conduct disorder	0.000433	0.00759	CbGpPWpGaD
Epinastine—Desipramine—HTR2A—conduct disorder	0.000425	0.0435	CrCbGaD
Epinastine—HTR7—GPCR ligand binding—CGA—conduct disorder	0.000413	0.00724	CbGpPWpGaD
Epinastine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000404	0.00707	CbGpPWpGaD
Epinastine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000397	0.00695	CbGpPWpGaD
Epinastine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000361	0.00633	CbGpPWpGaD
Epinastine—Imipramine—HTR2A—conduct disorder	0.00036	0.0369	CrCbGaD
Epinastine—Amitriptyline—HTR2A—conduct disorder	0.000358	0.0366	CrCbGaD
Epinastine—HTR7—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000355	0.00621	CbGpPWpGaD
Epinastine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000347	0.00609	CbGpPWpGaD
Epinastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000347	0.00607	CbGpPWpGaD
Epinastine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00034	0.00596	CbGpPWpGaD
Epinastine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000316	0.00554	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—CGA—conduct disorder	0.000305	0.00534	CbGpPWpGaD
Epinastine—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000304	0.00532	CbGpPWpGaD
Epinastine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000302	0.00529	CbGpPWpGaD
Epinastine—HRH2—GPCR ligand binding—DRD4—conduct disorder	0.000302	0.00529	CbGpPWpGaD
Epinastine—HTR7—brain—conduct disorder	0.000281	0.0407	CbGeAlD
Epinastine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000281	0.00491	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—CGA—conduct disorder	0.000277	0.00485	CbGpPWpGaD
Epinastine—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.000274	0.00479	CbGpPWpGaD
Epinastine—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000272	0.00476	CbGpPWpGaD
Epinastine—ADRA1A—brain—conduct disorder	0.000271	0.0393	CbGeAlD
Epinastine—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.000265	0.00463	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—CGA—conduct disorder	0.000264	0.00462	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.000259	0.00454	CbGpPWpGaD
Epinastine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000259	0.00453	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.000241	0.00422	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—CGA—conduct disorder	0.000234	0.00409	CbGpPWpGaD
Epinastine—HTR7—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000231	0.00405	CbGpPWpGaD
Epinastine—HTR7—GPCR ligand binding—DRD4—conduct disorder	0.000231	0.00405	CbGpPWpGaD
Epinastine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000227	0.00398	CbGpPWpGaD
Epinastine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000227	0.00397	CbGpPWpGaD
Epinastine—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.000223	0.0039	CbGpPWpGaD
Epinastine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000222	0.00389	CbGpPWpGaD
Epinastine—CYP2B6—Biological oxidations—COMT—conduct disorder	0.000216	0.00378	CbGpPWpGaD
Epinastine—CYP2B6—brain—conduct disorder	0.000215	0.0311	CbGeAlD
Epinastine—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.000214	0.00376	CbGpPWpGaD
Epinastine—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.000213	0.00373	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—CGA—conduct disorder	0.000212	0.00371	CbGpPWpGaD
Epinastine—HRH1—brain—conduct disorder	0.00021	0.0304	CbGeAlD
Epinastine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000207	0.00362	CbGpPWpGaD
Epinastine—ADRA2A—brain—conduct disorder	0.000206	0.0298	CbGeAlD
Epinastine—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000198	0.00347	CbGpPWpGaD
Epinastine—HRH2—GPCR ligand binding—HTR2A—conduct disorder	0.000197	0.00345	CbGpPWpGaD
Epinastine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000195	0.00341	CbGpPWpGaD
Epinastine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000194	0.0034	CbGpPWpGaD
Epinastine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000191	0.00335	CbGpPWpGaD
Epinastine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000191	0.00334	CbGpPWpGaD
Epinastine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000188	0.00329	CbGpPWpGaD
Epinastine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000183	0.00321	CbGpPWpGaD
Epinastine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000177	0.0031	CbGpPWpGaD
Epinastine—HTR2A—brain—conduct disorder	0.000176	0.0254	CbGeAlD
Epinastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000171	0.003	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—DRD4—conduct disorder	0.000171	0.00299	CbGpPWpGaD
Epinastine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000168	0.00294	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CGA—conduct disorder	0.000164	0.00286	CbGpPWpGaD
Epinastine—CYP2D6—brain—conduct disorder	0.00016	0.0231	CbGeAlD
Epinastine—HRH2—Signaling by GPCR—DRD4—conduct disorder	0.000155	0.00272	CbGpPWpGaD
Epinastine—HTR7—GPCR ligand binding—HTR2A—conduct disorder	0.000151	0.00264	CbGpPWpGaD
Epinastine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00015	0.00263	CbGpPWpGaD
Epinastine—HTR7—Circadian rythm related genes—EP300—conduct disorder	0.00015	0.00262	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.00015	0.00262	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000149	0.00261	CbGpPWpGaD
Epinastine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000149	0.00261	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000148	0.0026	CbGpPWpGaD
Epinastine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000148	0.00259	CbGpPWpGaD
Epinastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000148	0.00259	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000148	0.00259	CbGpPWpGaD
Epinastine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000147	0.00257	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000146	0.00256	CbGpPWpGaD
Epinastine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000145	0.00254	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000145	0.00254	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.000136	0.00238	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.000136	0.00238	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CGA—conduct disorder	0.000135	0.00237	CbGpPWpGaD
Epinastine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000135	0.00236	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.000135	0.00236	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.000133	0.00233	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—WASF1—conduct disorder	0.000131	0.0023	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—DRD4—conduct disorder	0.000131	0.00229	CbGpPWpGaD
Epinastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000127	0.00222	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CGA—conduct disorder	0.000125	0.00219	CbGpPWpGaD
Epinastine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000124	0.00218	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.000124	0.00216	CbGpPWpGaD
Epinastine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000121	0.00212	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—DRD4—conduct disorder	0.000119	0.00208	CbGpPWpGaD
Epinastine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000117	0.00206	CbGpPWpGaD
Epinastine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000116	0.00202	CbGpPWpGaD
Epinastine—ABCB1—brain—conduct disorder	0.000115	0.0166	CbGeAlD
Epinastine—HRH2—GPCR downstream signaling—HTR2A—conduct disorder	0.000111	0.00195	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—HTR2A—conduct disorder	0.000101	0.00177	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—WASF1—conduct disorder	0.0001	0.00176	CbGpPWpGaD
Epinastine—CYP3A4—Biological oxidations—COMT—conduct disorder	9.81e-05	0.00172	CbGpPWpGaD
Epinastine—CYP3A4—Biological oxidations—MAOA—conduct disorder	9.75e-05	0.00171	CbGpPWpGaD
Epinastine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	9.68e-05	0.0017	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	9.65e-05	0.00169	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	9.47e-05	0.00166	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—DRD4—conduct disorder	9.16e-05	0.0016	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	8.8e-05	0.00154	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—CGA—conduct disorder	8.73e-05	0.00153	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	8.53e-05	0.00149	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	8.37e-05	0.00147	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	8.36e-05	0.00146	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	8.2e-05	0.00144	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—CGA—conduct disorder	8.18e-05	0.00143	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CGA—conduct disorder	8.02e-05	0.0014	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CGA—conduct disorder	8e-05	0.0014	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CGA—conduct disorder	7.85e-05	0.00138	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—HTR2A—conduct disorder	7.75e-05	0.00136	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	7.62e-05	0.00133	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	7.6e-05	0.00133	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—DRD4—conduct disorder	7.59e-05	0.00133	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	7.45e-05	0.0013	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CGA—conduct disorder	7.3e-05	0.00128	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—DRD4—conduct disorder	7.02e-05	0.00123	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	6.92e-05	0.00121	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—WASF1—conduct disorder	6.43e-05	0.00113	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—WASF1—conduct disorder	6.42e-05	0.00112	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	6.29e-05	0.0011	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	6.28e-05	0.0011	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CGA—conduct disorder	6.04e-05	0.00106	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—HTR2A—conduct disorder	5.98e-05	0.00105	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	5.85e-05	0.00102	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CGA—conduct disorder	5.69e-05	0.000996	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	5.45e-05	0.000955	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	5.35e-05	0.000937	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	4.97e-05	0.000871	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	4.95e-05	0.000867	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	4.86e-05	0.000851	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—HTR2A—conduct disorder	4.58e-05	0.000802	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	4.51e-05	0.000791	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—DRD4—conduct disorder	4.49e-05	0.000787	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—DRD4—conduct disorder	4.48e-05	0.000785	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	4.4e-05	0.00077	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—EP300—conduct disorder	4.17e-05	0.00073	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	4.09e-05	0.000716	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—COMT—conduct disorder	3.94e-05	0.00069	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—MAOA—conduct disorder	3.91e-05	0.000685	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CGA—conduct disorder	3.72e-05	0.000651	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—COMT—conduct disorder	3.69e-05	0.000647	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—MAOA—conduct disorder	3.67e-05	0.000642	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—EP300—conduct disorder	3.17e-05	0.000554	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—HTR2A—conduct disorder	2.92e-05	0.000512	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	2.87e-05	0.000503	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—COMT—conduct disorder	2.72e-05	0.000477	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—MAOA—conduct disorder	2.71e-05	0.000474	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	2.67e-05	0.000467	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—COMT—conduct disorder	2.57e-05	0.00045	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—MAOA—conduct disorder	2.55e-05	0.000446	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—EP300—conduct disorder	2.43e-05	0.000425	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—EP300—conduct disorder	1.69e-05	0.000296	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—COMT—conduct disorder	1.68e-05	0.000294	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—MAOA—conduct disorder	1.67e-05	0.000292	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—EP300—conduct disorder	1.58e-05	0.000277	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.55e-05	0.000272	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EP300—conduct disorder	1.55e-05	0.000271	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EP300—conduct disorder	1.52e-05	0.000266	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EP300—conduct disorder	1.41e-05	0.000247	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—EP300—conduct disorder	1.17e-05	0.000205	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—EP300—conduct disorder	1.1e-05	0.000193	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—EP300—conduct disorder	7.2e-06	0.000126	CbGpPWpGaD
